» Articles » PMID: 18519695

Artesunate Derived from Traditional Chinese Medicine Induces DNA Damage and Repair

Overview
Journal Cancer Res
Specialty Oncology
Date 2008 Jun 4
PMID 18519695
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Artesunate is a semisynthetic derivative from artemisinin, a natural product from the Chinese herb Artemisia annua L. It exerts antimalarial activity, and, additionally, artemisinin and its derivatives are active against cancer cells. The active moiety is an endoperoxide bridge. Its cleavage leads to the formation of reactive oxygen species and carbon-centered radicals. These highly reactive molecules target several proteins in Plasmodia, which is thought to result in killing of the microorganism. DNA damage induced by artemisinins has not yet been described. Here, we show that artesunate induces apoptosis and necrosis. It also induces DNA breakage in a dose-dependent manner as shown by single-cell gel electrophoresis. This genotoxic effect was confirmed by measuring the level of gamma-H2AX, which is considered to be an indication of DNA double-strand breaks (DSB). Polymerase beta-deficient cells were more sensitive than the wild-type to artesunate, indicating that the drug induces DNA damage that is repaired by base excision repair. irs1 and VC8 cells defective in homologous recombination (HR) due to inactivation of XRCC2 and BRCA2, respectively, were more sensitive to artesunate than the corresponding wild-type. This was also true for XR-V15B cells defective in nonhomologous end-joining (NHEJ) due to inactivation of Ku80. The data indicate that DSBs induced by artesunate are repaired by the HR and NHEJ pathways. They suggest that DNA damage induced by artesunate contributes to its therapeutic effect against cancer cells.

Citing Articles

Effects of artemisinin and cisplatin on the malignant progression of oral leukoplakia. In vitro and in vivo study.

Dutra M, Malta I, de Almeida Lanca M, de Vasconcellos L, Adorno-Farias D, Jara J J Cancer Res Clin Oncol. 2024; 150(8):390.

PMID: 39154308 PMC: 11330948. DOI: 10.1007/s00432-024-05924-x.


In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer.

Elbadawi M, Efferth T Handb Exp Pharmacol. 2024; 287():95-121.

PMID: 38797749 DOI: 10.1007/164_2024_716.


Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.

Mao L, Deng G, Li M, Lu S, Jiang W, Yu X Eur J Med Res. 2024; 29(1):293.

PMID: 38773551 PMC: 11110347. DOI: 10.1186/s40001-024-01882-9.


L. Polyphenols Enhance the Anticancer Effect of β-Lapachone in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells.

Jung E, Kim H, Shin S, Kim G, Jung J, Hong S Int J Mol Sci. 2023; 24(24).

PMID: 38139333 PMC: 10743427. DOI: 10.3390/ijms242417505.


Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications.

Kaina B J Clin Med. 2023; 12(23).

PMID: 38068493 PMC: 10707404. DOI: 10.3390/jcm12237442.